18th Annual Report: Top 100 biotechnology companies
The biotechnology industry is in a funding crisis as companies reel from the effects of a struggling economy.
By Andrew Humphreys and Steven Niles

To the point
H is for healthcare hell
By Christiane Truelove
 

Specialty reps: the smaller, smarter sales force
Marketers must rethink their sales-force models as product portfolios become increasingly weighted toward specialty medicine.
By Steven Niles


2009 DTC Update: “E-Dimensions” of Pharmaceutical Advertising
From Websites to blogs, Podcasts, and social networks, the landscape of direct-to-consumer advertising for pharmaceutical marketing continues to shift.
By ORC Guideline

The behavior detectives
A small group of behavioral scientists at healthcare ad agencies are attempting to divine the motivations behind patient noncompliance – and how to change them.
By Joshua Slatko

Gastrointestinal market in flux
Gastrointestinal market growth is expected to come from treating irritable bowel diseases as PPI blockbusters near patent expiration.
By Gina-Louise Monari

Sales & Marketing
Taking aim at a well-known form of DTC, Representative James Moran, D-Va., has introduced a bill in the House of Representatives that would require the FCC to treat as indecent any radio or television commercial for a medication for erectile dysfunction or male enhancement, and not allow any such advertising between the hours of 6 a.m. and 10 p.m.
By Joshua Slatko

Pharma Business
With the initiation of the BioLaunch project in France, Sanofi-Aventis is investing nearly €200 million ($264.1 million) in pursuit of the company’s first cell-culture biotechnology platform.
By Steven Niles

People on the move
Roche and Genentech are working fast to create a more cohesive company, following the completion of their merger.
By Gina-Louise Monari

Adwise
A new multi-disciplinary forum marks a historic change for the industry by including advertising agency creative executives in the process of developing advertising standards.
By Gina-Louise Monari

e-Marketing
The continuing iPhone phenomenon is offering new opportunities to healthcare marketers every day.
By Joshua Slatko

FDA Files
FDA is requesting a budget of $3.2 billion to protect and promote the public health as part of the President’s fiscal-year 2010 budget – a 19% increase compared with the current FDA fiscal-year budget.
By Steven Niles

Drug Approvals
Avastin has received approvals to treat two debilitating forms of cancer.
By Gina-Louise Monari
 

CSOs and the specialty sales transition
Med Ad News spoke with Nancy Lurker, CEO, PDI Inc., about how contract sales organizations can help the pharmaceutical industry to fill its specialty sales force needs.

Behavioral science at work: Purohit Navigation
Ahnal Purohit, Ph.D. gave Med Ad News several examples of her agency’s behavioral science work in patient compliance.